| COLLEGIUM PHARMAC.DL-,001 |
| USA |
| Gesundheit |
| US19459J1043 / A14SUV |
| 354 (Frankfurt) / COLL (NASDAQ) |
| FRA:354, ETR:354, 354:GR, NASDAQ:COLL |
| - |
| https://www.collegiumphar.. |
|
Collegium Pharmaceutical Inc. is a biotechnology company specializing in the development and commercialization of innovative medications aimed at addressing under-treated medical conditions in pain ma..
>Volltext.. |
| 1204.17 Mio. EUR |
| 1742.05 Mio. EUR |
| 643.02 Mio. EUR |
| 330.16 Mio. EUR |
| 49.64 Mio. EUR |
| 1.56 EUR |
| 795.22 Mio. EUR |
| 144.34 Mio. EUR |
| 247.09 Mio. EUR |
| 0.67 |
| 19.87% |
| -37.41% |
| - |
| - |
| - |
| - |
| COLLEGIUM PHARMACEUTICAL, COLLEGIUM PHARMACEUTICALS, COLLEGIUM PHARMA |
| 26.02.26 |
|